Key E&C GOP Ask Providers To Detail How 340B Savings Are Used

September 20, 2017 at 8:19 PM
As part of an ongoing investigation into the 340B drug discount program, House Energy & Commerce Chair Greg Walden (R-OR) and oversight subcommittee Chair Tim Murphy (R-PA) are asking 340B providers to detail the savings they are receiving from the program, who the drugs go to and how savings are used. Earlier this year, Walden, Murphy and health subcommittee Chair Michael Burgess (R-TX) -- who did not sign the most recent letter -- told the Health Resources and Services Administration...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.